Sajitha Sachchithanantham - Publications

Bringing back 'significance' to MGUS.

Journal: Rheumatology (Oxford, England)

Published: January 28, 2026

Progressive Multifocal Leukoencephalopathy (PML) in 2 Patients Treated With Elranatamab.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 23, 2025

Is there a representative quality-of-life questionnaire for patients with AL amyloidosis?-systematic literature review.

Journal: British journal of haematology

Published: March 07, 2023

The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: May 03, 2022

A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis.

Journal: British journal of haematology

Published: March 15, 2022

Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis.

Journal: Heart (British Cardiac Society)

Published: December 17, 2021

Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.

Journal: European heart journal

Published: October 27, 2021

Cardiac Magnetic Resonance-Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid.

Journal: Circulation. Cardiovascular imaging

Published: April 20, 2021

Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis.

Journal: British journal of haematology

Published: April 02, 2021

Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data.

Journal: British journal of haematology

Published: March 21, 2021

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib.

Journal: Blood cancer journal

Published: February 14, 2021

Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.

Journal: European journal of haematology

Published: October 26, 2020